ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.020,50
0,64%
S&P 500
5.128,44
1,27%
Dow Jones
38.731,47
1,32%
Euro vs US Dollar
1,0775
0,42%
Bitcoin
61.635,95
4,25%
Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Apellis Pharmaceuticals Inc (APLS)

  7. Apellis Pharmaceuticals Inc (APLS) News

APLS Apellis Pharmaceuticals Inc

47,90
0,41 (0,86%)
Zuletzt aktualisiert: 15:36:43
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Apellis Pharmaceuticals Inc APLS NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
Upgrade Icon
0,41 0,86% 47,90 15:36:43
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
48,46 47,38 48,56 47,49
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
01.5.202413:00GLOBEApellis Announces 11 Oral Presentations at the Association..
26.4.202413:15GLOBEApellis Announces Pegcetacoplan MAA Review Has Been Reset to..
23.4.202413:00GLOBEApellis Pharmaceuticals to Host Conference Call on May 7,..
04.4.202422:05GLOBEApellis Pharmaceuticals Announces Inducement Grants Under..
01.4.202413:00GLOBEApellis Pharmaceuticals to Host a Fireside Chat at the 23rd..
11.3.202421:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11.3.202412:00GLOBEApellis Appoints Leading Expert Dr. Philip Ferrone as Chief..
08.3.202422:10EDGAR2Form 144 - Report of proposed sale of securities
08.3.202413:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.3.202422:05GLOBEApellis Pharmaceuticals Announces Inducement Grants Under..
05.3.202422:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.3.202422:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01.3.202422:25EDGAR2Form 144 - Report of proposed sale of securities
01.3.202419:37EDGAR2Form 144 - Report of proposed sale of securities
29.2.202423:10EDGAR2Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
27.2.202413:35EDGAR2Form S-8 - Securities to be offered to employees in employee..
27.2.202413:30EDGAR2Form 8-K - Current report
27.2.202413:05GLOBEApellis Pharmaceuticals Reports Fourth Quarter and Full Year..
27.2.202413:01EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
26.2.202413:00GLOBEApellis Pharmaceuticals to Present at Upcoming Investor..
20.2.202413:00GLOBEApellis Pharmaceuticals to Host Conference Call on February..
14.2.202423:18EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14.2.202416:04EDGAR2Form SC 13G - Statement of acquisition of beneficial..
14.2.202415:23EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13.2.202423:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.2.202423:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.2.202422:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.2.202422:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.2.202422:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12.2.202421:46EDGAR2Form 144 - Report of proposed sale of securities
12.2.202421:43EDGAR2Form 144 - Report of proposed sale of securities
12.2.202421:28EDGAR2Form 144 - Report of proposed sale of securities
12.2.202421:27EDGAR2Form 144 - Report of proposed sale of securities
12.2.202421:22EDGAR2Form 144 - Report of proposed sale of securities
12.2.202421:19EDGAR2Form 144 - Report of proposed sale of securities
06.2.202422:05GLOBEApellis Pharmaceuticals Announces Inducement Grants Under..
31.1.202422:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31.1.202422:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31.1.202422:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31.1.202422:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31.1.202422:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31.1.202422:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31.1.202422:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31.1.202422:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31.1.202422:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30.1.202416:50EDGAR2Form 144 - Report of proposed sale of securities
30.1.202416:04EDGAR2Form 144 - Report of proposed sale of securities
29.1.202421:22EDGAR2Form 144 - Report of proposed sale of securities
29.1.202421:21EDGAR2Form 144 - Report of proposed sale of securities
29.1.202421:21EDGAR2Form 144 - Report of proposed sale of securities

Kürzlich von Ihnen besucht

NASDAQ
APLS
Apellis Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten